Jagsonpal Pharmaceuticals Ltd. (IN:JAGSNPHARM)
:JAGSNPHARM
Want to see IN:JAGSNPHARM full AI Analyst Report?
Total Valuation
Jagsonpal Pharmaceuticals Ltd. has a market cap or net worth of ₹14.25B. The enterprise value is ₹14.27B.
Market Cap₹14.25B
Enterprise Value₹14.27B
Share Statistics
Jagsonpal Pharmaceuticals Ltd. has 67,139,150 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding67,139,150
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Jagsonpal Pharmaceuticals Ltd.’s return on equity (ROE) is 0.16 and return on invested capital (ROIC) is 12.56%.
Return on Equity (ROE)0.16
Return on Assets (ROA)0.14
Return on Invested Capital (ROIC)12.56%
Return on Capital Employed (ROCE)0.17
Revenue Per Employee2.80M
Profits Per Employee561.15K
Employee Count1,025
Asset Turnover0.91
Inventory Turnover7.13
Valuation Ratios
The current PE Ratio of Jagsonpal Pharmaceuticals Ltd. is 37.1. Jagsonpal Pharmaceuticals Ltd.’s PEG ratio is -1.29.
PE Ratio37.1
PS Ratio4.35
PB Ratio4.53
Price to Fair Value4.53
Price to FCF26.78
Price to Operating Cash Flow60.47
PEG Ratio-1.29
Income Statement
In the last 12 months, Jagsonpal Pharmaceuticals Ltd. had revenue of 2.87B and earned 430.82M in profits. Earnings per share was 6.40.
Revenue2.87B
Gross Profit1.83B
Operating Income486.30M
Pretax Income575.18M
Net Income430.82M
EBITDA679.90M
Earnings Per Share (EPS)6.40
Cash Flow
In the last 12 months, operating cash flow was 246.75M and capital expenditures -980.00K, giving a free cash flow of 245.77M billion.
Operating Cash Flow246.75M
Free Cash Flow245.77M
Free Cash Flow per Share3.66
Dividends & Yields
Jagsonpal Pharmaceuticals Ltd. pays an annual dividend of ₹2.5, resulting in a dividend yield of 1.24%
Dividend Per Share₹2.5
Dividend Yield1.24%
Payout Ratio26.82%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.99
52-Week Price Change-10.27%
50-Day Moving Average180.19
200-Day Moving Average210.81
Relative Strength Index (RSI)61.24
Average Volume (3m)3.85K
Important Dates
Jagsonpal Pharmaceuticals Ltd. upcoming earnings date is May 26, 2026, TBA (Confirmed).
Last Earnings DateJan 21, 2026
Next Earnings DateMay 26, 2026
Ex-Dividend Date―
Financial Position
Jagsonpal Pharmaceuticals Ltd. as a current ratio of 5.06, with Debt / Equity ratio of 2.96%
Current Ratio5.06
Quick Ratio4.54
Debt to Market Cap0.00
Net Debt to EBITDA-0.03
Interest Coverage Ratio47.31
Taxes
In the past 12 months, Jagsonpal Pharmaceuticals Ltd. has paid 144.36M in taxes.
Income Tax144.36M
Effective Tax Rate0.25
Enterprise Valuation
Jagsonpal Pharmaceuticals Ltd. EV to EBITDA ratio is 18.35, with an EV/FCF ratio of 26.74.
EV to Sales4.34
EV to EBITDA18.35
EV to Free Cash Flow26.74
EV to Operating Cash Flow26.66
Balance Sheet
Jagsonpal Pharmaceuticals Ltd. has ₹1.59B in cash and marketable securities with ₹88.36M in debt, giving a net cash position of ₹1.50B billion.
Cash & Marketable Securities₹1.59B
Total Debt₹88.36M
Net Cash₹1.50B
Net Cash Per Share₹22.41
Tangible Book Value Per Share₹29.45
Margins
Gross margin is 63.66%, with operating margin of 16.93%, and net profit margin of 15.00%.
Gross Margin63.66%
Operating Margin16.93%
Pretax Margin20.03%
Net Profit Margin15.00%
EBITDA Margin23.67%
EBIT Margin20.38%
Analyst Forecast
The average price target for Jagsonpal Pharmaceuticals Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast6.89%
EPS Growth Forecast-23.34%